Skip to content
Fencer Intel
critical 10.0

CVE-2022-1517 json

3.2.1 EXECUTION WITH UNNECESSARY PRIVILEGES CWE-250

published 4y ago modified 4mo ago also EUVD-2022-24815

cvss
10.0
version 3.1, CNA
cisa kev
Not listed
not in CISA's catalog
epss
1.8%
EPSS 1.8% chance of exploitation in 30 days, percentile 78%
public exploits
0
none known

Summary

LRM utilizes elevated privileges. An unauthenticated malicious actor can upload and execute code remotely at the operating system level, which can allow an attacker to change settings, configurations, software, or access sensitive data on the affected produc. An attacker could also exploit this vulnerability to access APIs not intended for general use and interact through the network.

Is CVE-2022-1517 in your stack? Fencer shows which of your repositories are affected as soon as an advisory lands, and opens the fix as a pull request.

Check with Fencer

Vendor advisories

What the vendors themselves say about their products: affected, fixed or not affected, and what to do.

cisa ICSA-22-153-02 updated cvss 10.0

Illumina Local Run Manager

  • Illumina iSeq 100 Instrument LRM >= 1.3, <= 3.1 Illumina MiniSeq Instrument LRM >= 1.3, <= 3.1 Illumina MiSeq Dx LRM >= 1.3, <= 3.1 Illumina MiSeq Instrument LRM >= 1.3, <= 3.1 Illumina NextSeq 500 Instrument LRM >= 1.3, <= 3.1 Illumina NextSeq 550 Instrument LRM >= 1.3, <= 3.1
    +1 more products
    Illumina NextSeq 550Dx LRM >= 1.3, <= 3.1
    affected: mitigation “For instruments connected to the Internet, the software patch is available for download.” support.illumina.com

From CISA ICS and IT advisories (CSAF, https://github.com/cisagov/CSAF), a U.S. Government work; changed: reduced to products, statuses and remediations. CISA notification · csaf

CISA SSVC

Exploitation
none
Automatable
yes
Technical impact
total
Assessed
last yr.

Exploit prediction

1.82% chance of exploitation in the next 30 days, higher than 78% of all scored CVEs (FIRST EPSS, 2026-11-09).

CVSS scores

assigned by version score vector
CNA 3.1 10.0 CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H
NVD 3.1 9.8 CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
NVD 2.0 10.0 AV:N/AC:L/Au:N/C:C/I:C/A:C

Affected products

  • Illumina NextSeq 550Dx
  • Illumina MiSeq Dx
  • Illumina NextSeq 500 Instrument
  • Illumina NextSeq 550 Instrument
  • Illumina MiSeq Instrument
  • Illumina iSeq 100 Instrument
  • Illumina MiniSeq Instrument

Classification

Weakness
  • CWE-250 Execution with Unnecessary Privileges
  • CWE-269 Improper Privilege Management

References

Sources

Fencer Intel keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.